Clinical Trial Update: Natalizumab Treatment of Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Natalizumab for progressive multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multiple Sclerosis

Drugs mentioned

• Tysabri (Natalizumab)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis | Phase 2 | Status: COMPLETED